The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 87 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Antifungal Agents  [Clear All Filters]
2022
Panagopoulou, P., & Roilides E. (2022).  Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections.. Expert Opin Pharmacother. 23(2), 175-199.
2019
P White, L., Barnes R. A., Gorton R., Cruciani M., & Loeffler J. (2019).  Comment on: T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study.. J Antimicrob Chemother. 74(2), 532-533.
Dotis, J., Printza N., Stabouli S., Karava V., Gkogka C., Vyzantiadis T-A., et al. (2019).  Disseminated mucormycosis in an adolescent kidney transplant recipient.. Kidney Int. 95(1), 236.
Tsekoura, M., Ioannidou M., Pana Z-D., Haidich A-B., Antachopoulos C., Iosifidis E., et al. (2019).  Efficacy and Safety of Echinocandins for the Treatment of Invasive Candidiasis in Children: A Meta-analysis.. Pediatr Infect Dis J. 38(1), 42-49.
Mantadakis, E., & Tragiannidis A. (2019).  Invasive Fungal Infections in the Pediatric Intensive Care Unit.. Pediatr Infect Dis J. 38(9), e216-e218.
Roilides, E., Carlesse F., Leister-Tebbe H., Conte U., Yan J. L., Liu P., et al. (2019).  A Prospective, Open-label Study to Assess the Safety, Tolerability and Efficacy of Anidulafungin in the Treatment of Invasive Candidiasis in Children 2 to <18 Years of Age.. Pediatr Infect Dis J. 38(3), 275-279.
Samaras, K., Markantonatou A-M., Karapiperis D., Digonis P., Kartalis N., Kostogloudis N., et al. (2019).  Saksenaea vasiformis infections: A case of an immunocompetent adult after mild injury and a literature review.. J Mycol Med. 29(3), 260-264.
Chatzivasileiou, P., & Vyzantiadis T-A. (2019).  Vaginal yeast colonisation: From a potential harmless condition to clinical implications and management approaches-A literature review.. Mycoses. 62(8), 638-650.
2018
Vyzantiadis, T-A., Yannaki E., Oliver D. A., Markantonatou A-M., Boussiou Z., Louka A., et al. (2018).  Alternative approaches to the therapeutic drug monitoring of prophylactic posaconazole in haematology patients.. J Mycol Med. 28(1), 65-69.
Ullmann, A. J., Aguado J. M., Arikan-Akdagli S., Denning D. W., Groll A. H., Lagrou K., et al. (2018).  Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.. Clin Microbiol Infect. 24 Suppl 1, e1-e38.
Maertens, J. A., Girmenia C., Brüggemann R. J., Duarte R. F., Kibbler C. C., Ljungman P., et al. (2018).  European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated . J Antimicrob Chemother. 73(12), 3221-3230.
Pana, Z. Dorothea, Kotzadamis D., & Roilides E. (2018).  Invasive Candidiasis in Pediatric Intensive Care Unit: More Challenges.. Pediatr Infect Dis J. 37(12), 1309-1311.
Bongomin, F., Harris C., Hayes G., Kosmidis C., & Denning D. W. (2018).  Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis.. PLoS One. 13(4), e0193732.
Pana, Z. Dorothea, Kourti M., Vikelouda K., Vlahou A., Katzilakis N., Papageorgiou M., et al. (2018).  Voriconazole Antifungal Prophylaxis in Children With Malignancies: A Nationwide Study.. J Pediatr Hematol Oncol. 40(1), 22-26.
2017
Gamaletsou, M. N., Rammaert B., Bueno M. A., Sipsas N. V., Moriyama B., Kontoyiannis D. P., et al. (2017).  Aspergillus arthritis: analysis of clinical manifestations, diagnosis, and treatment of 31 reported cases.. Med Mycol. 55(3), 246-254.
Taj-Aldeen, S. J., Gamaletsou M. N., Rammaert B., Sipsas N. V., Zeller V., Roilides E., et al. (2017).  Bone and joint infections caused by mucormycetes: A challenging osteoarticular mycosis of the twenty-first century.. Med Mycol. 55(7), 691-704.
Kosmidis, C., & Muldoon E. G. (2017).  Challenges in the management of chronic pulmonary aspergillosis.. Med Mycol. 55(1), 63-68.
Queiroz-Telles, F., de Hoog S., Santos D. Wagner C. L., Salgado C. Guedes, Vicente V. Aparecida, Bonifaz A., et al. (2017).  Chromoblastomycosis.. Clin Microbiol Rev. 30(1), 233-276.
Kyriakidis, I., Tragiannidis A., Munchen S., & Groll A. H. (2017).  Clinical hepatotoxicity associated with antifungal agents.. Expert Opin Drug Saf. 16(2), 149-165.
Katragkou, A., McCarthy M., Meletiadis J., Hussain K., Moradi P. W., Strauss G. E., et al. (2017).  In vitro combination therapy with isavuconazole against Candida spp.. Med Mycol. 55(8), 859-868.
Katragkou, A., Williams M., Sternberg S., Pantazatos D., Roilides E., & Walsh T. J. (2017).  Micafungin alters the amino acid, nucleic acid and central carbon metabolism of Candida albicans at subinhibitory concentrations: novel insights into mechanisms of action.. J Antimicrob Chemother. 72(3), 712-716.
Tsentemeidou, A., Vyzantiadis T-A., Kyriakou A., Sotiriadis D., & Patsatsi A. (2017).  Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study.. Mycoses. 60(12), 830-835.
Risslegger, B., Zoran T., Lackner M., Aigner M., Sánchez-Reus F., Rezusta A., et al. (2017).  A prospective international Aspergillus terreus survey: an EFISG, ISHAM and ECMM joint study.. Clin Microbiol Infect. 23(10), 776.e1-776.e5.
2016
Pana, Z-D., Vikelouda K., & Roilides E. (2016).  Diagnosis of invasive fungal diseases in pediatric patients.. Expert Rev Anti Infect Ther. 14(12), 1203-1213.
Aminnejad, M., Cogliati M., Duan S., Arabatzis M., Tintelnot K., Castañeda E., et al. (2016).  Identification and Characterization of VNI/VNII and Novel VNII/VNIV Hybrids and Impact of Hybridization on Virulence and Antifungal Susceptibility Within the C. neoformans/C. gattii Species Complex.. PLoS One. 11(10), e0163955.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.